HIGHLIGHTS
- who: Holly Keane from the Development process The WISDOM Study was approved by the University of California, San Francisco (UCSF) Institutional Review Board, which included the development and pilot of our risk assessment toolInformed consent was obtained from all human participants. The Women Informed to Screen Depending on Measures of risk (WISDOM) study is registered onas NCT02620852. The primary focus was three-fold: to incorporate personalized risk assessments have published the Article: Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial, in the Journal: (JOURNAL) of 27/05/2021 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.